Showing 1,095 results

Filters Content type: News, Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection

News
5 March 2013
Hepatitis C treatment

Patient Dilemma: Treat Hepatitis C Now or Hold Out?

Editor's pick
Wall Street Journal
5 March 2013
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients

News
5 March 2013
Hepatitis C treatment

Milk Thistle Drug May Help Control HCV Replication after Liver Transplant

Editor's pick
HIVandhepatitis.com
2 March 2013
Hepatitis C treatment side-effects

Health Canada Warns Of Serious Skin Reactions From Hepatitis C Drug

Editor's pick
RTT News
1 March 2013
Hepatitis C treatment

Pakistan: Low cost Hepatitis C treatment: ‘Everything is heading in the right direction – on paper’

Editor's pick
Express Tribune
28 February 2013
Hepatitis C treatment

Pakistan: Hepatitis C patients get the axe as hospitals stop treatment

Editor's pick
The Express Tribune
28 February 2013
Hepatitis C treatment

Study shows value of hepatitis C therapy for HIV co-infected patients with compensated cirrhosis

News
28 February 2013
Hepatitis C treatment

Hepatitis C Model Delivers Great Care Anywhere

Editor's pick
Infectious Disease Special Edition
25 February 2013
Hepatitis C transmission & prevention

Republic of Georgia plagued by hepatitis C

Editor's pick
Vaccine News Daily
20 February 2013
Hepatitis C transmission & prevention

Scotland: Project launched to tackle spread of Hepatitis C

Editor's pick
The Scotsman
20 February 2013
Hepatitis C treatment

A 'Killer' of a Reason to Treat Hepatitis C: Video

Editor's pick
Medscape (requires registration)
18 February 2013
Hepatitis C treatment

Victrelis (boceprevir) label updates

Editor's pick
FDA
18 February 2013
Access to healthcare

Have a heart, save my liver!

Editor's pick
HepCoalition.org
14 February 2013
Hepatitis C treatment

IL28B genotype had limited effect on telaprevir response in HCV patients

Editor's pick
Healio Hepatology
6 February 2013
Hepatitis C treatment

Interferon May Be Harmful in Retreatment of Hepatitis C

Editor's pick
Medscape (requires registration)
31 January 2013
Hepatitis C treatment

Infographic: Doctor-patient interactions about hepatitis C

Editor's pick
Health Care Communication News
30 January 2013
New & experimental hepatitis C treatment

Hepatitis C progress in pipeline: New drugs to treat virus expected be available in 2014-15

Editor's pick
Chicago Tribune
29 January 2013
Access to healthcare

Support Inclusion of Pegylated Interferon in the World Health Organization’s Essential Medicines List

Editor's pick
Treatment Action Group
23 January 2013
Hepatitis C symptoms & diagnosis

Rapid pace of liver damage in recent HCV co-infection

Editor's pick
CATIE
21 January 2013
Hepatitis C symptoms & diagnosis

Copy of Rapid pace of liver damage in recent HCV co-infection

Editor's pick
CATIE
21 January 2013
Hepatitis C treatment

AASLD Updated Practice Guideline: Use and Interpretation of HCV RNA Results During Triple Therapy

Editor's pick
Manual Items
15 January 2013
Hepatitis C treatment

Support improves hepatitis C treatment completion and response rates among drug users

News
2 January 2013
Hepatitis C transmission & prevention

HIV11: Sexually transmitted HCV rising among HIV+ gay men in Europe, but more are getting treated

Editor's pick
HIVandhepatitis.com
17 December 2012